Waterfront Wealth Inc. Takes Position in Intuitive Surgical, Inc. $ISRG

Waterfront Wealth Inc. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, Holdings Channel.com reports. The firm purchased 390 shares of the medical equipment provider’s stock, valued at approximately $212,000.

A number of other large investors have also made changes to their positions in ISRG. Brighton Jones LLC raised its holdings in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Golden State Wealth Management LLC increased its stake in Intuitive Surgical by 13.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,757 shares of the medical equipment provider’s stock valued at $870,000 after buying an additional 212 shares during the period. Ameritas Advisory Services LLC increased its stake in Intuitive Surgical by 5.9% in the 1st quarter. Ameritas Advisory Services LLC now owns 1,724 shares of the medical equipment provider’s stock valued at $878,000 after buying an additional 96 shares during the period. Mather Group LLC. increased its stake in Intuitive Surgical by 26.2% in the 1st quarter. Mather Group LLC. now owns 2,771 shares of the medical equipment provider’s stock valued at $1,372,000 after buying an additional 576 shares during the period. Finally, DAVENPORT & Co LLC increased its stake in Intuitive Surgical by 2.1% in the 1st quarter. DAVENPORT & Co LLC now owns 113,727 shares of the medical equipment provider’s stock valued at $56,240,000 after buying an additional 2,302 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.4%

Shares of ISRG opened at $537.59 on Thursday. The company’s fifty day moving average is $461.96 and its 200-day moving average is $498.01. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $192.72 billion, a price-to-earnings ratio of 71.11, a price-to-earnings-growth ratio of 5.01 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the business posted $1.84 EPS. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on ISRG shares. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $625.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Argus upped their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a research note on Monday. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Finally, Daiwa Capital Markets upped their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 2,800 shares of the company’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $546.27, for a total transaction of $1,529,556.00. Following the sale, the insider directly owned 17,120 shares of the company’s stock, valued at approximately $9,352,142.40. This represents a 14.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 96,011 shares of company stock worth $50,309,042 in the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.